|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
3
|
Resverlogix Corp.
|
Dec 01, 2021 08:10PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
3
|
Resverlogix Corp.
|
Dec 01, 2021 10:44PM
|
|
Re: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Aug 29, 2017 06:25PM
|
|
Re: Article - COVID-19 Lung Problems May Start in Blood Vessels
|
3
|
Resverlogix Corp.
|
Apr 27, 2020 10:39PM
|
|
Re: Article - COVID-19 Lung Problems May Start in Blood Vessels
|
3
|
Resverlogix Corp.
|
Apr 27, 2020 10:39PM
|
|
Re: Bloom Burton - Thoughts, Impressions and quotes....
|
3
|
Resverlogix Corp.
|
May 07, 2018 08:48AM
|
|
Re: NEJM Article: Another possibility it raises
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 02:14PM
|
|
Another, but already on company site
|
3
|
Resverlogix Corp.
|
Apr 14, 2023 01:38PM
|
|
Re: BD-selectivity vs. BET protein selectivity
|
3
|
Resverlogix Corp.
|
Oct 06, 2018 07:06PM
|
|
Re: BD-selectivity vs. BET protein selectivity
|
3
|
Resverlogix Corp.
|
Oct 06, 2018 07:08PM
|
|
Here's one while we wait again - inflammation & obesity (huge market)
|
3
|
Resverlogix Corp.
|
Feb 13, 2018 04:53PM
|
|
Re: One week later....
|
3
|
Resverlogix Corp.
|
May 20, 2021 12:15PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 25, 2017 09:38PM
|
|
Re: Zenith Meeting audio?
|
3
|
Zenith Epigenetics
|
Nov 14, 2019 07:34AM
|
|
Re: Congratulations to Imtesty/alberta clipper on winning the Share Price Contest
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 11:39PM
|
|
More encouraging...
|
3
|
Resverlogix Corp.
|
Aug 03, 2022 02:35PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
3
|
Resverlogix Corp.
|
Sep 26, 2017 07:39AM
|
|
Re: So BETonMACE failed the primary endpoint. What's next?
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 05:20PM
|
|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
3
|
Resverlogix Corp.
|
Jun 13, 2021 01:54AM
|
|
Re: BET inhibition and epilepsy
|
3
|
Resverlogix Corp.
|
Jun 09, 2021 02:06AM
|
